In the circumstances of obesity-induced insulin resistance and hyperinsulinemia, genetic alterations in PI3K pathways that enhance signal intensity may cause further exaggeration of signaling, promoting tumor development. The gene discussed is PIK3CG; the disease is Hyperinsulinemia.